Targeting the Root Cause of Cystic Fibrosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|9|933-944

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.9, 2015-08, pp. : 933-944

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting neutrophil elastase in cystic fibrosis

By Kelly Emer   Greene Catherine M   McElvaney Noel G  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 145-157

Informa Healthcare

Access to resources Recommend Favorite

Targeting ENaC as a Molecular Suspect in Cystic Fibrosis

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. : 951-957

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetics in Cystic Fibrosis: Epigenetic Targeting of a Genetic Disease

By  

Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. : 976-987

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Airway Inflammation in Cystic Fibrosis in Children: Past, Present, and Future

By Pressler Tacjana  

Pediatric Drugs, Vol. 13, Iss. 3, 2011-06 ,pp. : 141-147

Adis International

Access to resources Recommend Favorite

Targeting a Genetic Killer: Novel Disease-Modifying Therapies for Cystic Fibrosis

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 4, 2006-01 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite